论文部分内容阅读
我院自1975～1980年底,以乙型肝炎后肝硬化脾脏为供体提取转移因子(简称TF),配合五味子制剂治疗慢性肝炎,现将治疗达3～6个月的434例进行小结,重点分析和探讨转移因子治疗慢性肝炎的适应类型。一、研究方法1.病例选择和分组:本文病例的选用均符合1978年杭州肝炎会议有关慢性肝炎(甲种分型法)的诊断标准。治疗病例随机分成二组,转移因子配五味子制剂组(简称TF治疗组)和单纯五味子组作为对照(简称对照组)。每
In our hospital from the end of 1975 to the end of 1980, the transfer factor (TF) was extracted from the spleen of posthepatitic cirrhotic patients as donor, combined with schisandra preparation for the treatment of chronic hepatitis, and 434 cases of treatment up to 3 ~ 6 months were summarized. To analyze and explore the type of adaptation factor of transfer factor in the treatment of chronic hepatitis. First, the research methods 1. Case Selection and Grouping: The selection of cases in this paper are in line with the hepatitis B in Hangzhou in 1978 on the diagnosis of chronic hepatitis (A type classification) diagnostic criteria. Treatment cases were randomly divided into two groups, transfer factor with Schisandra preparation group (TF treatment group) and simple Schisandra group as a control (referred to as the control group). each